Azelis Group NV

Brussels Stock Exchange AZE.BR

Azelis Group NV EBITDA for the year ending December 31, 2023: USD 518.97 M

Azelis Group NV EBITDA is USD 518.97 M for the year ending December 31, 2023, a 7.36% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Azelis Group NV EBITDA for the year ending December 31, 2022 was USD 483.37 M, a 77.31% change year over year.
Azelis Group NV EBITDA for the year ending December 31, 2021 was USD 272.61 M, a 13.37% change year over year.
Azelis Group NV EBITDA for the year ending December 31, 2020 was USD 240.46 M, a 24.17% change year over year.
Azelis Group NV EBITDA for the year ending December 31, 2019 was USD 193.65 M, a 2,286.05% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Brussels Stock Exchange: AZE.BR

Azelis Group NV

CEO	Ms. Anna Bertona
IPO Date	Sept. 17, 2021
Location	Belgium
Headquarters	Posthofbrug 12
Employees	3,481
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Petrochemicals

Description

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients in Belgium and internationally. It serves various segments in life sciences, including personal care, pharma, food and health, specialty agri/horti, and homecare and industrial chemicals; and industrial chemicals industry, such as CASE, rubber and plastic additives, lubricants and metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper applications. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium. Azelis Group NV operates as a subsidiary of Akita I S.À R.L.

Key trends

Past 5 years